Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - MERIDIAN BIOSCIENCE INC | d621584d10k.htm |
| EX-31.2 - EX-31.2 - MERIDIAN BIOSCIENCE INC | d621584dex312.htm |
| EX-31.1 - EX-31.1 - MERIDIAN BIOSCIENCE INC | d621584dex311.htm |
| EX-23 - EX-23 - MERIDIAN BIOSCIENCE INC | d621584dex23.htm |
| EX-21 - EX-21 - MERIDIAN BIOSCIENCE INC | d621584dex21.htm |
| EX-10.10.10 - EX-10.10.10 - MERIDIAN BIOSCIENCE INC | d621584dex101010.htm |
| EX-10.7 - EX-10.7 - MERIDIAN BIOSCIENCE INC | d621584dex107.htm |
Exhibit 32
Certification of Chief Executive Officer and Chief Financial Officer
Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the filing with the Securities and Exchange Commission of the Annual Report of Meridian Bioscience, Inc. (the “Company”) on Form 10-K for the period ended September 30, 2018 (the “Report”), the undersigned officers of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of their knowledge:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| /s/ Jack Kenny |
| Jack Kenny |
| Chief Executive Officer |
| November 29, 2018 |
| /s/ Melissa A. Lueke |
| Melissa A. Lueke |
| Executive Vice President and |
| Chief Financial Officer |
| November 29, 2018 |